CN101712973A - 常温核酸扩增链替换反应试剂及常温核酸扩增方法 - Google Patents
常温核酸扩增链替换反应试剂及常温核酸扩增方法 Download PDFInfo
- Publication number
- CN101712973A CN101712973A CN200910153518A CN200910153518A CN101712973A CN 101712973 A CN101712973 A CN 101712973A CN 200910153518 A CN200910153518 A CN 200910153518A CN 200910153518 A CN200910153518 A CN 200910153518A CN 101712973 A CN101712973 A CN 101712973A
- Authority
- CN
- China
- Prior art keywords
- nucleic acid
- acid amplification
- normal temperature
- chain
- albumen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000003199 nucleic acid amplification method Methods 0.000 title claims abstract description 91
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 78
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 75
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 75
- 230000003321 amplification Effects 0.000 title claims abstract description 74
- 239000012070 reactive reagent Substances 0.000 title abstract 2
- DRBBFCLWYRJSJZ-UHFFFAOYSA-N N-phosphocreatine Chemical compound OC(=O)CN(C)C(=N)NP(O)(O)=O DRBBFCLWYRJSJZ-UHFFFAOYSA-N 0.000 claims abstract description 24
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims abstract description 20
- 102000001218 Rec A Recombinases Human genes 0.000 claims abstract description 20
- 108010055016 Rec A Recombinases Proteins 0.000 claims abstract description 20
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 claims abstract description 17
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims abstract description 14
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims abstract description 14
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 14
- 229950007002 phosphocreatine Drugs 0.000 claims abstract description 12
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims abstract description 11
- 239000007997 Tricine buffer Substances 0.000 claims abstract description 11
- 229910001629 magnesium chloride Inorganic materials 0.000 claims abstract description 10
- 102000002490 Rad51 Recombinase Human genes 0.000 claims abstract description 4
- 108010068097 Rad51 Recombinase Proteins 0.000 claims abstract description 4
- 238000006243 chemical reaction Methods 0.000 claims description 68
- 239000003153 chemical reaction reagent Substances 0.000 claims description 31
- 238000010839 reverse transcription Methods 0.000 claims description 22
- SEQKRHFRPICQDD-UHFFFAOYSA-N N-tris(hydroxymethyl)methylglycine Chemical compound OCC(CO)(CO)[NH2+]CC([O-])=O SEQKRHFRPICQDD-UHFFFAOYSA-N 0.000 claims description 20
- 241000894006 Bacteria Species 0.000 claims description 18
- 230000000968 intestinal effect Effects 0.000 claims description 18
- 101100300807 Drosophila melanogaster spn-A gene Proteins 0.000 claims description 15
- 239000002299 complementary DNA Substances 0.000 claims description 15
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 14
- UZMAPBJVXOGOFT-UHFFFAOYSA-N Syringetin Natural products COC1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UZMAPBJVXOGOFT-UHFFFAOYSA-N 0.000 claims description 10
- KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 claims description 10
- -1 polyoxyethylene Polymers 0.000 claims description 8
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 7
- 239000007850 fluorescent dye Substances 0.000 claims description 7
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 7
- 239000000284 extract Substances 0.000 claims description 6
- 238000013016 damping Methods 0.000 claims description 5
- 239000012530 fluid Substances 0.000 claims description 5
- CGNLCCVKSWNSDG-UHFFFAOYSA-N SYBR Green I Chemical group CN(C)CCCN(CCC)C1=CC(C=C2N(C3=CC=CC=C3S2)C)=C2C=CC=CC2=[N+]1C1=CC=CC=C1 CGNLCCVKSWNSDG-UHFFFAOYSA-N 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 34
- 101710126859 Single-stranded DNA-binding protein Proteins 0.000 abstract description 10
- 101710176276 SSB protein Proteins 0.000 abstract description 5
- 239000000243 solution Substances 0.000 abstract description 5
- 230000035945 sensitivity Effects 0.000 abstract description 3
- 230000001419 dependent effect Effects 0.000 abstract description 2
- 241000193830 Bacillus <bacterium> Species 0.000 abstract 2
- 239000002202 Polyethylene glycol Substances 0.000 abstract 2
- 210000001072 colon Anatomy 0.000 abstract 2
- 229920001223 polyethylene glycol Polymers 0.000 abstract 2
- 239000001103 potassium chloride Substances 0.000 abstract 1
- 235000011164 potassium chloride Nutrition 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 62
- 108020004414 DNA Proteins 0.000 description 42
- 238000012360 testing method Methods 0.000 description 32
- 239000000047 product Substances 0.000 description 30
- 238000005516 engineering process Methods 0.000 description 26
- 241000700605 Viruses Species 0.000 description 19
- 239000008280 blood Substances 0.000 description 19
- 210000004369 blood Anatomy 0.000 description 19
- 238000013461 design Methods 0.000 description 17
- 238000001514 detection method Methods 0.000 description 17
- 241000725303 Human immunodeficiency virus Species 0.000 description 16
- 201000010099 disease Diseases 0.000 description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 12
- 229910052751 metal Inorganic materials 0.000 description 12
- 239000002184 metal Substances 0.000 description 12
- 230000008569 process Effects 0.000 description 11
- 239000000126 substance Substances 0.000 description 10
- 238000003745 diagnosis Methods 0.000 description 9
- 238000001962 electrophoresis Methods 0.000 description 9
- 244000000010 microbial pathogen Species 0.000 description 9
- 230000001717 pathogenic effect Effects 0.000 description 9
- 238000000605 extraction Methods 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 238000010805 cDNA synthesis kit Methods 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 6
- 239000003292 glue Substances 0.000 description 6
- 238000007403 mPCR Methods 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 239000012634 fragment Substances 0.000 description 5
- 150000002739 metals Chemical class 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- 238000012181 QIAquick gel extraction kit Methods 0.000 description 4
- 238000000246 agarose gel electrophoresis Methods 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 238000006555 catalytic reaction Methods 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 239000008367 deionised water Substances 0.000 description 4
- 229910021641 deionized water Inorganic materials 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 238000001502 gel electrophoresis Methods 0.000 description 4
- ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 4
- 238000003384 imaging method Methods 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 238000009413 insulation Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 239000011535 reaction buffer Substances 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 238000005382 thermal cycling Methods 0.000 description 4
- 210000001541 thymus gland Anatomy 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 239000013614 RNA sample Substances 0.000 description 3
- 238000000137 annealing Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000011901 isothermal amplification Methods 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 230000009385 viral infection Effects 0.000 description 3
- 208000030507 AIDS Diseases 0.000 description 2
- 238000001712 DNA sequencing Methods 0.000 description 2
- 208000028782 Hereditary disease Diseases 0.000 description 2
- 208000024556 Mendelian disease Diseases 0.000 description 2
- 108700020796 Oncogene Proteins 0.000 description 2
- 208000019802 Sexually transmitted disease Diseases 0.000 description 2
- 239000004964 aerogel Substances 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 238000012864 cross contamination Methods 0.000 description 2
- 238000000151 deposition Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 238000013467 fragmentation Methods 0.000 description 2
- 238000006062 fragmentation reaction Methods 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 238000003259 recombinant expression Methods 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000011218 segmentation Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 238000011179 visual inspection Methods 0.000 description 2
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 208000031886 HIV Infections Diseases 0.000 description 1
- 108010014594 Heterogeneous Nuclear Ribonucleoprotein A1 Proteins 0.000 description 1
- 108060004795 Methyltransferase Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 241001631646 Papillomaviridae Species 0.000 description 1
- 108010076039 Polyproteins Proteins 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 102000018120 Recombinases Human genes 0.000 description 1
- 108010091086 Recombinases Proteins 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 108020005202 Viral DNA Proteins 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000009329 sexual behaviour Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Images
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (12)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910153518A CN101712973B (zh) | 2009-09-30 | 2009-09-30 | 常温核酸扩增链替换反应试剂及常温核酸扩增方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910153518A CN101712973B (zh) | 2009-09-30 | 2009-09-30 | 常温核酸扩增链替换反应试剂及常温核酸扩增方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101712973A true CN101712973A (zh) | 2010-05-26 |
CN101712973B CN101712973B (zh) | 2012-09-05 |
Family
ID=42416971
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200910153518A Active CN101712973B (zh) | 2009-09-30 | 2009-09-30 | 常温核酸扩增链替换反应试剂及常温核酸扩增方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101712973B (zh) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102491883A (zh) * | 2011-12-16 | 2012-06-13 | 东华大学 | 聚乙二醇镁及其制备方法和应用 |
CN104818263A (zh) * | 2015-05-07 | 2015-08-05 | 浙江泰晶生物科技有限公司 | 用于常温等温核酸大片段体外扩增的蛋白酶及扩增方法 |
CN104845965A (zh) * | 2015-04-28 | 2015-08-19 | 华侨大学 | 一种利用多聚化合物提高rca扩增效率的方法 |
CN105087795A (zh) * | 2015-08-17 | 2015-11-25 | 广州和实生物技术有限公司 | 一种恒温扩增技术 |
CN105112399A (zh) * | 2015-08-17 | 2015-12-02 | 广州和实生物技术有限公司 | 一种荧光恒温扩增技术 |
CN105543402A (zh) * | 2016-03-02 | 2016-05-04 | 刘国宪 | 等温核酸扩增反应试剂及等温核酸扩增方法 |
CN107177684A (zh) * | 2017-06-15 | 2017-09-19 | 刘琳 | 一种恒温核酸扩增反应试剂 |
CN110484656A (zh) * | 2019-09-03 | 2019-11-22 | 深圳市慧思基因科技有限公司 | 一种犬细小病毒干燥型实时荧光pcr检测试剂的检测方法 |
CN116042783A (zh) * | 2022-12-12 | 2023-05-02 | 深圳市卓润生物科技有限公司 | 核酸扩增试剂盒和应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1904647A4 (en) * | 2005-07-15 | 2009-11-04 | Yeda Res & Dev | METHOD AND KITS FOR IDENTIFYING NUCLEIC ACID SEQUENCES |
US20080118917A1 (en) * | 2006-11-21 | 2008-05-22 | Applera Corporation | Isothermal SNP Detection Method |
-
2009
- 2009-09-30 CN CN200910153518A patent/CN101712973B/zh active Active
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102491883A (zh) * | 2011-12-16 | 2012-06-13 | 东华大学 | 聚乙二醇镁及其制备方法和应用 |
CN102491883B (zh) * | 2011-12-16 | 2014-01-08 | 东华大学 | 聚乙二醇镁及其制备方法和应用 |
CN104845965A (zh) * | 2015-04-28 | 2015-08-19 | 华侨大学 | 一种利用多聚化合物提高rca扩增效率的方法 |
CN104818263A (zh) * | 2015-05-07 | 2015-08-05 | 浙江泰晶生物科技有限公司 | 用于常温等温核酸大片段体外扩增的蛋白酶及扩增方法 |
CN105087795A (zh) * | 2015-08-17 | 2015-11-25 | 广州和实生物技术有限公司 | 一种恒温扩增技术 |
CN105112399A (zh) * | 2015-08-17 | 2015-12-02 | 广州和实生物技术有限公司 | 一种荧光恒温扩增技术 |
CN105543402A (zh) * | 2016-03-02 | 2016-05-04 | 刘国宪 | 等温核酸扩增反应试剂及等温核酸扩增方法 |
CN105543402B (zh) * | 2016-03-02 | 2019-07-02 | 刘国宪 | 等温核酸扩增反应试剂及等温核酸扩增方法 |
CN107177684A (zh) * | 2017-06-15 | 2017-09-19 | 刘琳 | 一种恒温核酸扩增反应试剂 |
CN107177684B (zh) * | 2017-06-15 | 2021-02-02 | 刘琳 | 一种恒温核酸扩增反应试剂 |
CN110484656A (zh) * | 2019-09-03 | 2019-11-22 | 深圳市慧思基因科技有限公司 | 一种犬细小病毒干燥型实时荧光pcr检测试剂的检测方法 |
CN116042783A (zh) * | 2022-12-12 | 2023-05-02 | 深圳市卓润生物科技有限公司 | 核酸扩增试剂盒和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN101712973B (zh) | 2012-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101712973B (zh) | 常温核酸扩增链替换反应试剂及常温核酸扩增方法 | |
Pang et al. | Isothermal amplification and ambient visualization in a single tube for the detection of SARS-CoV-2 using loop-mediated amplification and CRISPR technology | |
Bialek et al. | Detection of Cryptococcus neoformans DNA in tissue samples by nested and real-time PCR assays | |
Gharizadeh et al. | Navigating the pandemic response life cycle: molecular diagnostics and immunoassays in the context of COVID-19 management | |
RU2727054C1 (ru) | Способ выявления кДНК коронавируса SARS-CoV-2 с помощью синтетических олигонуклеотидных праймеров в полимеразной цепной реакции | |
Ge et al. | A Palm Germ-Radar (PaGeR) for rapid and simple COVID-19 detection by reverse transcription loop-mediated isothermal amplification (RT-LAMP) | |
CN105112565A (zh) | 一种检测伪狂犬病毒ge基因的lamp检测方法 | |
EP3902929A1 (en) | Fast and portable microfluidic detection system as an alternative to salmonella's classical culture method | |
Li et al. | Development and clinical implications of a novel CRISPR-based diagnostic test for pulmonary Aspergillus fumigatus infection | |
EP2597162A1 (en) | Nucleic acid detection | |
CN114214455A (zh) | 乙肝病毒DNA快速定量引物探针及其CRISPR/Cas12b检测系统 | |
Qian et al. | Clustered regularly interspaced short palindromic Repeat/Cas12a mediated multiplexable and portable detection platform for GII genotype Porcine Epidemic Diarrhoea Virus Rapid diagnosis | |
CN107365684A (zh) | 一种纸微流控芯片及其核酸提取方法和等温扩增方法 | |
CN103525909A (zh) | 鲍曼不动杆菌实时荧光环介导等温扩增试剂盒 | |
CN107236827B (zh) | 猪传染性胃肠炎病毒检测试剂盒及检测方法 | |
CN102618627B (zh) | 核酸恒温扩增反应内参检测系统及试剂盒 | |
CN102399903B (zh) | 一种基孔肯雅病毒等温扩增检测试剂盒及其引物 | |
AU2020102421A4 (en) | A primer combination for detecting 2019ncov by loop-mediated isothermal amplification | |
WO2022156073A1 (zh) | 一种rap基因检测试剂盒、检测方法和应用及rap病毒检测试剂盒 | |
CN115725756A (zh) | 一种用于检测梅毒螺旋体的rpa引物组、试剂、试剂盒及其应用 | |
CN104894112B (zh) | 一种日本乙型脑炎病毒实时荧光等温扩增检测试剂盒及其引物和探针 | |
CN113957177A (zh) | Cva16检测引物及检测方法 | |
CN106191314B (zh) | 一种dna病毒的lamp检测试剂盒、检测方法及应用 | |
CN109266786A (zh) | 基于e184l基因的非洲猪瘟病毒检测试剂盒和检测方法 | |
CN111270010B (zh) | 一种检测SARS-CoV-2的环介导等温扩增检测引物组及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: ZHEJIANG TAIJING BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: NINGBO HUAYUE BIOTECHNOLOGY CO., LTD. Effective date: 20120331 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 315334 NINGBO, ZHEJIANG PROVINCE TO: 311121 HANGZHOU, ZHEJIANG PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20120331 Address after: Yuhang District, Hangzhou City, Zhejiang Province, 311121 West 1500 No. 6 floor 11 unit 5 Applicant after: Zhejiang Taijing Biotechnology Co., Ltd. Address before: 315334 Zhejiang province Cixi Chongshou Town Industrial Park Applicant before: Ningbo Huayue Biological Technology Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: CHENG QI Free format text: FORMER OWNER: ZHEJIANG TAIJING BIOTECHNOLOGY CO., LTD. Effective date: 20130125 Owner name: HUANG ZHENJU Effective date: 20130125 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 311121 HANGZHOU, ZHEJIANG PROVINCE TO: 100081 HAIDIAN, BEIJING |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130125 Address after: 100081 Institute of biology, Chinese Academy of Agricultural Sciences, 12 South Avenue, Beijing, Haidian District, Zhongguancun Patentee after: Cheng Qi Patentee after: Huang Zhenju Address before: Yuhang District, Hangzhou City, Zhejiang Province, 311121 West 1500 No. 6 floor 11 unit 5 Patentee before: Zhejiang Taijing Biotechnology Co., Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20180903 Address after: 314000 Room 101, block C, Chuang Chuang Road, Dayun Town, Jiashan, Jiaxing, Zhejiang, China, 101 Patentee after: Zhejiang Shan Shi Wo Knight Biotechnology Co., Ltd. Address before: 100081 Institute of biology, Chinese Academy of Agricultural Sciences, 12 Zhongguancun South Street, Haidian District, Beijing Co-patentee before: Huang Zhenju Patentee before: Cheng Qi |
|
TR01 | Transfer of patent right | ||
PP01 | Preservation of patent right |
Effective date of registration: 20200814 Granted publication date: 20120905 |
|
PP01 | Preservation of patent right | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20211110 Granted publication date: 20120905 |
|
PD01 | Discharge of preservation of patent | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211215 Address after: 100000 No. 302, unit 3, building 21, south yard, No. 2 Yuanmingyuan West Road, Haidian District, Beijing Patentee after: Cheng Qi Patentee after: Huang Zhenju Address before: 314000 Room 101, block C, Chuang Chuang Road, Dayun Town, Jiashan, Jiaxing, Zhejiang, China, 101 Patentee before: ZHEJIANG SHANCE HEQISHI BIOLOGICAL TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right |